We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current THAR market cap is 4.42M. The company's latest EPS is USD -0.7938 and P/E is -0.48.
| Quarter End | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.13M | -2.72M | -2.36M | -1.85M | -2.53M |
| Net Income | -2.13M | -2.69M | -2.34M | -1.82M | -2.47M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -2.17B | -3.21M | -6.88M | -9.46M |
| Net Income | -2.42B | -2.21M | -8.47M | -9.32M |
| Quarter End | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 7.83M | 4.72M | 4.6M | 3.17M | 10.95M |
| Total Liabilities | 717k | 1.52M | 1.53M | 1.41M | 1.82M |
| Total Equity | 7.12M | 3.2M | 3.07M | 1.76M | 9.13M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 294.8M | 622k | 6.69M | 10.95M |
| Total Liabilities | 4.01B | 5.31M | 1.15M | 1.82M |
| Total Equity | -3.72B | -4.69M | 5.54M | 9.13M |
| Quarter End | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -5.49M | -3.47M | -4.98M | -5.89M | -7.3M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 13.09M | 523k | 2.37M | 2.06M | 11.72M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.08B | -1.09M | -6.56M | -7.3M |
| Investing | N/A | N/A | N/A | N/A |
| Financing | 1.23B | 899k | 13.06M | 11.72M |
| Market Cap | 4.42M |
| Price to Earnings Ratio | -0.48 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.41 |
| Price to Book Ratio | 0.49 |
| Dividend Yield | - |
| Shares Outstanding | 11.74M |
| Average Volume (1 week) | 215.66k |
| Average Volume (1 Month) | 147.55k |
| 52 Week Change | -93.16% |
| 52 Week High | 9.50 |
| 52 Week Low | 0.3439 |
| Spread (Intraday) | 0.04 (10.29%) |
| Company Name | Tharimmune Inc |
| Address |
16192 coastal hwy lewes, delaware 19958 |
| Website | https://www.hillstreambio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
